Impact of 2004 ISUP/WHO classification on bladder cancer grading

Purpose To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG). Methods Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six path...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of urology 2015-12, Vol.33 (12), p.1929-1936
Hauptverfasser: Lokeshwar, Soum D., Ruiz-Cordero, Roberto, Hupe, Marie C., Jorda, Merce, Soloway, Mark S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1936
container_issue 12
container_start_page 1929
container_title World journal of urology
container_volume 33
creator Lokeshwar, Soum D.
Ruiz-Cordero, Roberto
Hupe, Marie C.
Jorda, Merce
Soloway, Mark S.
description Purpose To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG). Methods Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six pathologists were evaluated: low grade (LG): 249; HG: 791; Ta: 389; T1: 214; CIS: 95; ≥T2: 342. Differences in LG or HG cases (expressed as %BCa cases/year) were analyzed by Mann–Whitney test. Correlation between the year of diagnosis and clinical/pathological parameters was evaluated by logistic regression analyses. Results During the study period, BCa cases diagnosed as LG significantly decreased with a corresponding increase in HG cases. Nonlinear regression analysis indicated that ~2008 was the crossover point for grade migration; %LG: 31.8 ± 4.8 (2000–2007); 14.1 ± 7.0 (2008–2013); %HG: 68.2 ± 4.8 (2000–2007); 85.9 ± 6.9 (2008–2013), P  = 0.004. The grade migration was confined to Ta cases with %LG Ta cases diagnosed decreasing by 3.6-fold from 2000–2007 to 2008–2013 ( P  = 0.004). Univariate and multivariate analyses confirmed the grade migration following the adoption of the 2004 system ( P   0.05). Conclusions Implementation of the 2004 WHO/ISUP system caused a significant increase in pathologists grading Ta cases as HG; however, this increase did not seem to correlate with disease progression. Since LG and HG Ta tumors are treated differently, grade migration may impact the clinical management of BCa patients.
doi_str_mv 10.1007/s00345-015-1548-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1735910366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3873019401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-b245b4b8f14c7f2d15a877a7cb644909986c4769766c66ada5c72be2fb60bf13</originalsourceid><addsrcrecordid>eNp1kF1LwzAUhoMobk5_gDdS8MabupM0H-2dMtQNBhOceBmSNB0dXTuTFua_N7NTRBAC5yLPec85D0KXGG4xgBh7gISyGDCLMaNpvDtCQ0yTJE4F4cdoCILQmGZpMkBn3q8BsODATtGAsDRJOMdDdDfbbJVpo6aICACNZi-vz-O36SIylfK-LEqj2rKpo_B0pfLcusio2oSyciov69U5OilU5e3FoY7Q8vFhOZnG88XTbHI_jw2lpI01oUxTnRaYGlGQHDOVCqGE0ZzSDLIs5YYKngnODecqV8wIoi0pNAdd4GSEbvrYrWveO-tbuSm9sVWlatt0XmKRsAxDOCqg13_QddO5Oiz3ReFUACGBwj1lXOO9s4XcunKj3IfEIPd2ZW9XBrtyb1fuQs_VIbnTG5v_dHzrDADpAR--6pV1v0b_m_oJlrWCDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1735187022</pqid></control><display><type>article</type><title>Impact of 2004 ISUP/WHO classification on bladder cancer grading</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Lokeshwar, Soum D. ; Ruiz-Cordero, Roberto ; Hupe, Marie C. ; Jorda, Merce ; Soloway, Mark S.</creator><creatorcontrib>Lokeshwar, Soum D. ; Ruiz-Cordero, Roberto ; Hupe, Marie C. ; Jorda, Merce ; Soloway, Mark S.</creatorcontrib><description>Purpose To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG). Methods Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six pathologists were evaluated: low grade (LG): 249; HG: 791; Ta: 389; T1: 214; CIS: 95; ≥T2: 342. Differences in LG or HG cases (expressed as %BCa cases/year) were analyzed by Mann–Whitney test. Correlation between the year of diagnosis and clinical/pathological parameters was evaluated by logistic regression analyses. Results During the study period, BCa cases diagnosed as LG significantly decreased with a corresponding increase in HG cases. Nonlinear regression analysis indicated that ~2008 was the crossover point for grade migration; %LG: 31.8 ± 4.8 (2000–2007); 14.1 ± 7.0 (2008–2013); %HG: 68.2 ± 4.8 (2000–2007); 85.9 ± 6.9 (2008–2013), P  = 0.004. The grade migration was confined to Ta cases with %LG Ta cases diagnosed decreasing by 3.6-fold from 2000–2007 to 2008–2013 ( P  = 0.004). Univariate and multivariate analyses confirmed the grade migration following the adoption of the 2004 system ( P  &lt; 0.0001). Kaplan–Meier curves showed no significant differences between the two time intervals in terms of disease progression ( P  &gt; 0.05). Conclusions Implementation of the 2004 WHO/ISUP system caused a significant increase in pathologists grading Ta cases as HG; however, this increase did not seem to correlate with disease progression. Since LG and HG Ta tumors are treated differently, grade migration may impact the clinical management of BCa patients.</description><identifier>ISSN: 0724-4983</identifier><identifier>EISSN: 1433-8726</identifier><identifier>DOI: 10.1007/s00345-015-1548-x</identifier><identifier>PMID: 25833661</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aged ; Aged, 80 and over ; Bladder cancer ; Female ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Nephrology ; Oncology ; Original Article ; Pathology, Clinical ; Prognosis ; Reproducibility of Results ; Retrospective Studies ; Societies, Medical ; Urinary Bladder Neoplasms - classification ; Urinary Bladder Neoplasms - pathology ; Urology</subject><ispartof>World journal of urology, 2015-12, Vol.33 (12), p.1929-1936</ispartof><rights>Springer-Verlag Berlin Heidelberg 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-b245b4b8f14c7f2d15a877a7cb644909986c4769766c66ada5c72be2fb60bf13</citedby><cites>FETCH-LOGICAL-c442t-b245b4b8f14c7f2d15a877a7cb644909986c4769766c66ada5c72be2fb60bf13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00345-015-1548-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00345-015-1548-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25833661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lokeshwar, Soum D.</creatorcontrib><creatorcontrib>Ruiz-Cordero, Roberto</creatorcontrib><creatorcontrib>Hupe, Marie C.</creatorcontrib><creatorcontrib>Jorda, Merce</creatorcontrib><creatorcontrib>Soloway, Mark S.</creatorcontrib><title>Impact of 2004 ISUP/WHO classification on bladder cancer grading</title><title>World journal of urology</title><addtitle>World J Urol</addtitle><addtitle>World J Urol</addtitle><description>Purpose To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG). Methods Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six pathologists were evaluated: low grade (LG): 249; HG: 791; Ta: 389; T1: 214; CIS: 95; ≥T2: 342. Differences in LG or HG cases (expressed as %BCa cases/year) were analyzed by Mann–Whitney test. Correlation between the year of diagnosis and clinical/pathological parameters was evaluated by logistic regression analyses. Results During the study period, BCa cases diagnosed as LG significantly decreased with a corresponding increase in HG cases. Nonlinear regression analysis indicated that ~2008 was the crossover point for grade migration; %LG: 31.8 ± 4.8 (2000–2007); 14.1 ± 7.0 (2008–2013); %HG: 68.2 ± 4.8 (2000–2007); 85.9 ± 6.9 (2008–2013), P  = 0.004. The grade migration was confined to Ta cases with %LG Ta cases diagnosed decreasing by 3.6-fold from 2000–2007 to 2008–2013 ( P  = 0.004). Univariate and multivariate analyses confirmed the grade migration following the adoption of the 2004 system ( P  &lt; 0.0001). Kaplan–Meier curves showed no significant differences between the two time intervals in terms of disease progression ( P  &gt; 0.05). Conclusions Implementation of the 2004 WHO/ISUP system caused a significant increase in pathologists grading Ta cases as HG; however, this increase did not seem to correlate with disease progression. Since LG and HG Ta tumors are treated differently, grade migration may impact the clinical management of BCa patients.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bladder cancer</subject><subject>Female</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>Nephrology</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Pathology, Clinical</subject><subject>Prognosis</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Societies, Medical</subject><subject>Urinary Bladder Neoplasms - classification</subject><subject>Urinary Bladder Neoplasms - pathology</subject><subject>Urology</subject><issn>0724-4983</issn><issn>1433-8726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kF1LwzAUhoMobk5_gDdS8MabupM0H-2dMtQNBhOceBmSNB0dXTuTFua_N7NTRBAC5yLPec85D0KXGG4xgBh7gISyGDCLMaNpvDtCQ0yTJE4F4cdoCILQmGZpMkBn3q8BsODATtGAsDRJOMdDdDfbbJVpo6aICACNZi-vz-O36SIylfK-LEqj2rKpo_B0pfLcusio2oSyciov69U5OilU5e3FoY7Q8vFhOZnG88XTbHI_jw2lpI01oUxTnRaYGlGQHDOVCqGE0ZzSDLIs5YYKngnODecqV8wIoi0pNAdd4GSEbvrYrWveO-tbuSm9sVWlatt0XmKRsAxDOCqg13_QddO5Oiz3ReFUACGBwj1lXOO9s4XcunKj3IfEIPd2ZW9XBrtyb1fuQs_VIbnTG5v_dHzrDADpAR--6pV1v0b_m_oJlrWCDQ</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>Lokeshwar, Soum D.</creator><creator>Ruiz-Cordero, Roberto</creator><creator>Hupe, Marie C.</creator><creator>Jorda, Merce</creator><creator>Soloway, Mark S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20151201</creationdate><title>Impact of 2004 ISUP/WHO classification on bladder cancer grading</title><author>Lokeshwar, Soum D. ; Ruiz-Cordero, Roberto ; Hupe, Marie C. ; Jorda, Merce ; Soloway, Mark S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-b245b4b8f14c7f2d15a877a7cb644909986c4769766c66ada5c72be2fb60bf13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bladder cancer</topic><topic>Female</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>Nephrology</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Pathology, Clinical</topic><topic>Prognosis</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Societies, Medical</topic><topic>Urinary Bladder Neoplasms - classification</topic><topic>Urinary Bladder Neoplasms - pathology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lokeshwar, Soum D.</creatorcontrib><creatorcontrib>Ruiz-Cordero, Roberto</creatorcontrib><creatorcontrib>Hupe, Marie C.</creatorcontrib><creatorcontrib>Jorda, Merce</creatorcontrib><creatorcontrib>Soloway, Mark S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lokeshwar, Soum D.</au><au>Ruiz-Cordero, Roberto</au><au>Hupe, Marie C.</au><au>Jorda, Merce</au><au>Soloway, Mark S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of 2004 ISUP/WHO classification on bladder cancer grading</atitle><jtitle>World journal of urology</jtitle><stitle>World J Urol</stitle><addtitle>World J Urol</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>33</volume><issue>12</issue><spage>1929</spage><epage>1936</epage><pages>1929-1936</pages><issn>0724-4983</issn><eissn>1433-8726</eissn><abstract>Purpose To determine whether implementation of the 2004 WHO/ISUP bladder cancer (BCa) grading system caused a grade migration, i.e., more tumors being graded as high grade (HG). Methods Data on 1040 BCa cases from 668 patients treated at our institution between 2000 and 2013 and reviewed by six pathologists were evaluated: low grade (LG): 249; HG: 791; Ta: 389; T1: 214; CIS: 95; ≥T2: 342. Differences in LG or HG cases (expressed as %BCa cases/year) were analyzed by Mann–Whitney test. Correlation between the year of diagnosis and clinical/pathological parameters was evaluated by logistic regression analyses. Results During the study period, BCa cases diagnosed as LG significantly decreased with a corresponding increase in HG cases. Nonlinear regression analysis indicated that ~2008 was the crossover point for grade migration; %LG: 31.8 ± 4.8 (2000–2007); 14.1 ± 7.0 (2008–2013); %HG: 68.2 ± 4.8 (2000–2007); 85.9 ± 6.9 (2008–2013), P  = 0.004. The grade migration was confined to Ta cases with %LG Ta cases diagnosed decreasing by 3.6-fold from 2000–2007 to 2008–2013 ( P  = 0.004). Univariate and multivariate analyses confirmed the grade migration following the adoption of the 2004 system ( P  &lt; 0.0001). Kaplan–Meier curves showed no significant differences between the two time intervals in terms of disease progression ( P  &gt; 0.05). Conclusions Implementation of the 2004 WHO/ISUP system caused a significant increase in pathologists grading Ta cases as HG; however, this increase did not seem to correlate with disease progression. Since LG and HG Ta tumors are treated differently, grade migration may impact the clinical management of BCa patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>25833661</pmid><doi>10.1007/s00345-015-1548-x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0724-4983
ispartof World journal of urology, 2015-12, Vol.33 (12), p.1929-1936
issn 0724-4983
1433-8726
language eng
recordid cdi_proquest_miscellaneous_1735910366
source MEDLINE; Springer Online Journals Complete
subjects Aged
Aged, 80 and over
Bladder cancer
Female
Humans
Kaplan-Meier Estimate
Logistic Models
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Grading
Neoplasm Staging
Nephrology
Oncology
Original Article
Pathology, Clinical
Prognosis
Reproducibility of Results
Retrospective Studies
Societies, Medical
Urinary Bladder Neoplasms - classification
Urinary Bladder Neoplasms - pathology
Urology
title Impact of 2004 ISUP/WHO classification on bladder cancer grading
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T18%3A40%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%202004%20ISUP/WHO%20classification%20on%20bladder%20cancer%20grading&rft.jtitle=World%20journal%20of%20urology&rft.au=Lokeshwar,%20Soum%20D.&rft.date=2015-12-01&rft.volume=33&rft.issue=12&rft.spage=1929&rft.epage=1936&rft.pages=1929-1936&rft.issn=0724-4983&rft.eissn=1433-8726&rft_id=info:doi/10.1007/s00345-015-1548-x&rft_dat=%3Cproquest_cross%3E3873019401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1735187022&rft_id=info:pmid/25833661&rfr_iscdi=true